Your browser doesn't support javascript.
loading
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance).
Roboz, Gail J; Mandrekar, Sumithra J; Desai, Pinkal; Laumann, Kristina; Walker, Alison R; Wang, Eunice S; Kolitz, Jonathan E; Powell, Bayard L; Attar, Eyal C; Stock, Wendy; Bloomfield, Clara D; Kohlschmidt, Jessica; Mrózek, Krzysztof; Hassane, Duane C; Garraway, Levi; Jané-Valbuena, Judit; Baltay, Michele; Tracy, Adam; Marcucci, Guido; Stone, Richard M; Larson, Richard A.
Afiliación
  • Roboz GJ; Division of Hematology and Oncology, Department of Medicine, Weill Medical College, Cornell University, New York, NY.
  • Mandrekar SJ; New York Presbyterian Hospital, New York, NY.
  • Desai P; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Laumann K; Division of Hematology and Oncology, Department of Medicine, Weill Medical College, Cornell University, New York, NY.
  • Walker AR; New York Presbyterian Hospital, New York, NY.
  • Wang ES; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Kolitz JE; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Powell BL; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Attar EC; Monter Cancer Center, Northwell Health System, Lake Success, NY.
  • Stock W; Division of Hematology Oncology, Department of Medicine, Zucker School of Medicine, Hofstra Northwell, Lake Success, NY.
  • Bloomfield CD; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.
  • Kohlschmidt J; Massachusetts General Hospital, Boston, MA.
  • Mrózek K; University of Chicago Comprehensive Cancer Center, Chicago, IL.
  • Hassane DC; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Garraway L; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Jané-Valbuena J; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Baltay M; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Tracy A; Division of Hematology and Oncology, Department of Medicine, Weill Medical College, Cornell University, New York, NY.
  • Marcucci G; New York Presbyterian Hospital, New York, NY.
  • Stone RM; Dana-Farber/Partners CancerCare, Boston, MA.
  • Larson RA; Center for Cancer Precision Medicine, Department of Medicine, Harvard Medical School, Boston, MA.
Blood Adv ; 2(24): 3608-3617, 2018 12 26.
Article en En | MEDLINE | ID: mdl-30567725
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Bortezomib / Decitabina / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Bortezomib / Decitabina / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos